Stockreport

Intrexon on go to start clinical study of novel approach to treat type 1 diabetes [Seeking Alpha]

INTREXON CORP  (XON) 
Last intrexon corp earnings: 11/12 07:30 am Check Earnings Report
US:NYSE Investor Relations: investors.dna.com
PDF Intrexon on go to start clinical study of novel approach to treat type 1 diabetesThe FDA hassigned off on Intrexon (XON-2.8%) subsidiary ActoBio Therapeutics' IND, allow [Read more]